Hungarian pharmaceutical company Gedeon Richter announced the signing of a global collaboration agreement with Indian peer Hetero Labs on the joint development, registration and commercialization of a semaglutide injection, a generic of the anti-diabetic drug Ozempic, the Hungarian company has announced on thew website of the Budapest Stock Exchange. The agreement combines the companies’ complementary […]